Oyster Point Pharma, Inc. Total Long-Term Debt
Oyster Point Pharma, Inc. had Total Long-Term Debt of $92.22 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2022-11-10
- 2022-09-30: Long-term Debt $92.22M.
- 2022-06-30: Long-term Debt $91.44M.
- 2022-03-31: Long-term Debt $90.64M.
- 2021-12-31: Long-term Debt $89.81M.
| Period end | Long-term Debt |
|---|---|
| 2022-09-30 | $92.22M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $91.44M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $90.64M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $89.81M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $41.92M 10-Q · filed 2021-11-04 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 |